Windtree Therapeutics, Inc. – Common Stock Q2 EPS $(0.59) Up From $(1.42) YoY
Windtree Therapeutics, Inc. - Common Stock (NASDAQ:WINT) reported quarterly losses of $(0.59) per share. This is a 58.45 percent increase over losses of $(1.42) per share from the same period last year.